The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

Costs varied across 5 European countries, driven primarily by repeated primary care visits and parental work absences.

An industry group responds, "Other than clean water, arguably nothing has done more to improve public health than vaccines." ...